← Back
$CNTA All transactions

Centessa Pharmaceuticals plc

A

$ Value

$0

Shares

120,000

Price

$0

Filed

Feb 3

Insider

Name

Kanes Stephen

Title

Chief Medical Officer

CIK

0001612859

Roles

Officer

Transaction Details

Transaction Date

2026-02-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

120,000

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in four equal annual installments with the first such annual vesting being on February 2, 2027.

Filing Info

Accession No.

0001470831-26-000098

Form Type

4

Issuer CIK

0001847903

Kanes Stephen's History

Date Ticker Type Value
2026-02-02 CNTA A $0

Other Insiders at CNTA (90d)

Insider Bought Sold Last
Weinhoff Gregory M
Chief Business Officer
$2.6M 2026-03-26
Crowley John J
Chief Financial Officer
2026-02-02
Anderson Karen M.
Chief People Officer
$6.5M 2026-03-26
HUSSAIN IQBAL J
Chief Legal Officer
$1.0M 2026-02-02
Bush Tia L
Chief Technology & Quality Ofc
2026-02-02
Deferiere Raphael
Chief Accounting Officer
2026-02-02
Accardi Mario Alberto
Chief Executive Officer
2026-02-02